These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12732108)

  • 21. [Treatment of Helicobacter pylori infection. Whom to treat and with what?].
    Dehesa-Violante M
    Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):50-5. PubMed ID: 11464622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of a five times daily triple therapy regimen against Helicobacter pylori.
    Lynch DA; Sobala GM; Gallacher B; Dixon MF; Axon AT
    J Antimicrob Chemother; 1994 Apr; 33(4):877-9. PubMed ID: 8056709
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens.
    Michopoulos S; Tsibouris P; Bouzakis H; Balta A; Vougadiotis J; Broutet N; Kralios N
    Aliment Pharmacol Ther; 2000 Jun; 14(6):737-44. PubMed ID: 10848657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
    Kaviani MJ; Malekzadeh R; Vahedi H; Sotoudeh M; Kamalian N; Amini M; Massarrat S
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):915-9. PubMed ID: 11507355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori-positive duodenal ulcer: a long-term double-blind randomized study in patients healed with H2-receptor antagonists.
    Suriani R; Ravizza M; Pallante C; Mazzucco D; Cardesi E; Colozza M; Malandrino M; Oneglio R; Orso Giacone G; Dusio P; Vajo M
    Helicobacter; 1996 Sep; 1(3):151-4. PubMed ID: 9398896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The search for optimal Helicobacter pylori eradication regimen: a mid 1997 update.
    Deltenre M; De Bruyne L; Ntounda R; De Koster E; Lamy V
    Acta Gastroenterol Belg; 1998; 61(3):344-7. PubMed ID: 9795469
    [No Abstract]   [Full Text] [Related]  

  • 27. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
    Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
    [No Abstract]   [Full Text] [Related]  

  • 30. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    Fennerty MB
    Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
    [No Abstract]   [Full Text] [Related]  

  • 31. Quadruple therapy: the golden bullet or a drug too far?
    Moayyedi P
    Helicobacter; 1996 Jun; 1(2):123-4. PubMed ID: 9398891
    [No Abstract]   [Full Text] [Related]  

  • 32. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
    Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
    Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
    Aliment Pharmacol Ther; 2000 Aug; 14(8):991-9. PubMed ID: 10930892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-ulcer drugs. Indications in adults. French Agency of the Safety of Health Products].
    Presse Med; 2000 Jan; 29(2):86-94. PubMed ID: 10682037
    [No Abstract]   [Full Text] [Related]  

  • 35. The treatment of Helicobacter pylori infection.
    Pounder RE; Williams MP
    Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():35-41. PubMed ID: 9146789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The European meeting on Helicobacter pylori: therapeutic news from Lisbon.
    Peitz U; Menegatti M; Vaira D; Malfertheiner P
    Gut; 1998 Jul; 43 Suppl 1(Suppl 1):S66-9. PubMed ID: 9764044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eradication of Helicobacter pylori infection. A new therapy standard for duodenal ulcer].
    Caspary WF; Braden B
    Internist (Berl); 1996 Dec; 37(12):1204-11. PubMed ID: 9081921
    [No Abstract]   [Full Text] [Related]  

  • 38. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
    Janssen MJ; Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
    Aliment Pharmacol Ther; 2001 May; 15(5):613-24. PubMed ID: 11328254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 40. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy.
    Rinaldi V; Zullo A; De Francesco V; Hassan C; Winn S; Stoppino V; Faleo D; Attili AF
    Aliment Pharmacol Ther; 1999 Feb; 13(2):163-8. PubMed ID: 10102945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.